ResMed's execution continues to impress, and innovation remains key to growth prospects.
Strong sales momentum from first-quarter fiscal 2018 continued, with narrow-moat ResMed reporting another excellent quarter, ahead of our expectations and across all product categories. Net profit after tax, adjusted for one-off items related to changes in the U.S. tax reform, was USD 143.8 million on group revenue of USD 601.3 million, up 39% and 13%, respectively. The result reflected the continuing adoption of the AirSense 10 device platform, launched in 2015, complemented by subsequent launc...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.